Your browser is no longer supported. Please, upgrade your browser.
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E47.63 EPS (ttm)2.52 Insider Own0.30% Shs Outstand1.78B Perf Week-2.65%
Market Cap215.38B Forward P/E22.24 EPS next Y5.39 Insider Trans-6.90% Shs Float1.76B Perf Month4.80%
Income4.50B PEG3.03 EPS next Q1.28 Inst Own75.60% Short Float0.60% Perf Quarter11.31%
Sales34.61B P/S6.22 EPS this Y24.50% Inst Trans-0.04% Short Ratio2.12 Perf Half Y16.08%
Book/sh18.46 P/B6.49 EPS next Y6.51% ROA6.50% Target Price134.88 Perf Year51.26%
Cash/sh3.98 P/C30.13 EPS next 5Y15.74% ROE14.40% 52W Range61.61 - 128.54 Perf YTD9.40%
Dividend1.80 P/FCF68.07 EPS past 5Y7.80% ROI9.70% 52W High-6.81% Beta0.72
Dividend %1.50% Quick Ratio1.30 Sales past 5Y11.10% Gross Margin56.80% 52W Low94.42% ATR2.65
Employees109000 Current Ratio1.70 Sales Q/Q28.70% Oper. Margin15.80% RSI (14)47.07 Volatility2.05% 2.20%
OptionableYes Debt/Eq0.57 EPS Q/Q108.80% Profit Margin13.00% Rel Volume1.03 Prev Close121.58
ShortableYes LT Debt/Eq0.57 EarningsJan 27 BMO Payout56.80% Avg Volume4.96M Price119.78
Recom1.80 SMA20-3.08% SMA503.65% SMA20014.11% Volume5,197,681 Change-1.48%
Jan-28-21Upgrade BTIG Research Neutral → Buy $140
Sep-11-20Initiated Wolfe Research Outperform $124
Jun-01-20Downgrade Goldman Neutral → Sell $84
Mar-05-20Initiated Citigroup Buy $96
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Mar-01-21 06:25AM  
Feb-28-21 06:22AM  
Feb-26-21 11:30AM  
10:16AM  
09:26AM  
09:22AM  
09:01AM  
08:53AM  
Feb-25-21 05:45PM  
Feb-24-21 09:31AM  
Feb-23-21 04:20PM  
09:40AM  
Feb-19-21 02:47PM  
01:25PM  
Feb-18-21 07:15AM  
Feb-17-21 12:35PM  
Feb-16-21 04:09PM  
Feb-12-21 11:47AM  
10:38AM  
10:05AM  
09:19AM  
09:17AM  
08:58AM  
08:30AM  
06:40AM  
Feb-11-21 08:49PM  
12:24PM  
11:47AM  
10:35AM  
09:11AM  
08:50AM  
07:47AM  
06:55AM  
Feb-10-21 12:00PM  
11:31AM  
10:18AM  
10:14AM  
Feb-09-21 09:59AM  
09:56AM  
09:41AM  
06:50AM  
Feb-08-21 01:21PM  
09:14AM  
Feb-07-21 05:58AM  
Feb-06-21 10:59AM  
Feb-05-21 11:09AM  
09:50AM  
06:01AM  
02:00AM  
Feb-04-21 01:34PM  
12:25PM  
11:30AM  
11:25AM  
09:30AM  
09:29AM  
09:22AM  
08:07AM  
08:06AM  
07:47AM  
07:30AM  
Feb-03-21 10:42AM  
10:30AM  
09:48AM  
08:16AM  
Feb-02-21 01:11PM  
12:20PM  
10:10AM  
09:39AM  
08:35AM  
05:50AM  
03:53AM  
Feb-01-21 01:05PM  
12:00PM  
11:34AM  
08:00AM  
Jan-31-21 11:01PM  
Jan-30-21 06:35AM  
Jan-29-21 06:52AM  
Jan-28-21 11:07PM  
11:15AM  
08:03AM  
06:20AM  
Jan-27-21 04:24PM  
04:15PM  
03:00PM  
03:00PM  
10:49AM  
10:42AM  
09:54AM  
08:45AM  
08:15AM  
08:10AM  
07:30AM  
07:21AM  
04:01AM  
Jan-26-21 10:10AM  
07:45AM  
07:16AM  
Jan-22-21 08:29PM  
Jan-20-21 08:22AM  
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kumbier MichelleDirectorFeb 23Buy122.502,040249,9007,296Feb 25 06:05 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTFeb 22Sale121.8440048,73475,706Feb 23 07:05 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTFeb 16Sale128.4950564,88763,373Feb 18 05:57 PM
Funck Robert EEXECUTIVE VICE PRESIDENTFeb 02Option Exercise39.1231,3251,225,434193,542Feb 04 06:56 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 02Sale123.033,130385,08459,681Feb 03 07:20 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTFeb 01Option Exercise38.78203,3937,887,902355,289Feb 03 07:10 PM
Scoggins Christopher JSENIOR VICE PRESIDENTFeb 01Option Exercise44.8345,0002,017,20084,706Feb 03 07:14 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 01Option Exercise38.4018,750720,00081,561Feb 03 07:20 PM
MANNING JOSEPH JSENIOR VICE PRESIDENTFeb 01Sale122.7918,7502,302,26462,811Feb 03 07:20 PM
Scoggins Christopher JSENIOR VICE PRESIDENTFeb 01Sale123.2445,0005,545,80039,706Feb 03 07:14 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTFeb 01Sale123.47203,39325,113,252151,896Feb 03 07:10 PM
NOVAKOVIC PHEBE NDirectorDec 04Option Exercise34.9714,681513,43145,794Dec 08 05:58 PM
NOVAKOVIC PHEBE NDirectorDec 04Sale107.284,790513,84941,004Dec 08 05:58 PM
OSBORN WILLIAM ADirectorNov 24Option Exercise43.6421,448935,99179,745Nov 25 05:41 PM
Funck Robert EExecutive Vice President & CFOOct 26Option Exercise38.4083,3333,199,987265,550Oct 28 06:33 PM
Funck Robert EExecutive Vice President & CFOOct 26Sale108.8383,3339,068,955182,217Oct 28 06:33 PM
Wainer Andrea FExecutive Vice PresidentSep 30Option Exercise38.4030,0001,152,00074,080Oct 01 05:50 PM
Wainer Andrea FExecutive Vice PresidentSep 30Sale107.0130,0003,210,36044,080Oct 01 05:50 PM
Wainer Andrea FExecutive Vice PresidentSep 23Sale102.473,650374,03144,080Sep 25 05:06 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentSep 11Sale105.282,500263,20046,267Sep 15 06:14 PM
Ginascol John FExecutive Vice PresidentSep 01Option Exercise43.1672,0983,111,584136,775Sep 03 06:33 PM
BIRD ROGERSenior Vice PresidentSep 01Sale108.736,290683,92956,630Sep 03 05:52 PM
CAPEK JOHN MExecutive Vice PresidentAug 27Option Exercise27.0352,3001,413,857369,100Aug 31 06:27 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentAug 27Option Exercise47.0042,4791,996,513144,912Aug 31 06:28 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentAug 27Sale111.8642,4794,751,701102,433Aug 31 06:28 PM
CAPEK JOHN MExecutive Vice PresidentAug 27Sale111.8652,3005,850,278316,800Aug 31 06:27 PM
NOVAKOVIC PHEBE NDirectorJul 23Option Exercise25.053,73993,67732,046Jul 27 05:06 PM
NOVAKOVIC PHEBE NDirectorJul 23Sale100.7893394,02631,113Jul 27 05:06 PM
AUSTIN ROXANNE SDirectorJul 22Sale99.806,844683,03840,043Jul 23 05:07 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 21Option Exercise0.0023,008096,899Jul 23 05:04 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 21Sale98.0023,0082,254,78473,891Jul 23 05:04 PM
Earnhardt Lisa DExecutive Vice PresidentJun 10Sale90.8487279,21672,074Jun 12 05:07 PM
LANE ANDREW HExecutive Vice PresidentMay 05Option Exercise43.8280,0003,505,314145,822May 07 05:02 PM
LANE ANDREW HExecutive Vice PresidentMay 05Sale92.0080,0007,360,10465,822May 07 05:02 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentApr 28Sale93.183,724347,01248,767Apr 30 06:34 PM
Funck Robert EExecutive Vice President & CFOApr 21Option Exercise36.4236,7001,336,638206,072Apr 23 09:27 PM
Contreras JaimeSenior Vice PresidentApr 21Option Exercise57.12108,4126,192,995145,431Apr 23 09:26 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Option Exercise22.3950,1001,121,834366,900Apr 23 09:34 PM
Ginascol John FExecutive Vice PresidentApr 21Option Exercise38.4063,2002,426,880129,645Apr 23 09:41 PM
CAPEK JOHN MExecutive Vice PresidentApr 21Sale95.8750,1004,803,326316,800Apr 23 09:34 PM
Scoggins Christopher JSenior Vice PresidentApr 21Sale96.1041439,78539,706Apr 23 09:28 PM
Ginascol John FExecutive Vice PresidentApr 21Sale96.0063,2006,067,05166,445Apr 23 09:41 PM
Boudreau Philip PVice PresidentMar 13Sale82.0010,600869,20022,463Mar 16 06:47 PM
Watkin JaredSenior Vice PresidentMar 06Sale82.008,248676,33668,696Mar 10 05:06 PM
Funck Robert EExecutive Vice President & CFOMar 02Sale77.891,356105,619169,372Mar 03 05:28 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentMar 02Sale77.891,420110,60453,859Mar 03 05:27 PM
BIRD ROGERSenior Vice PresidentMar 02Sale77.8966651,87562,920Mar 03 05:23 PM
DALE MICHAEL DSenior Vice PresidentMar 02Sale77.8978761,29934,763Mar 03 05:21 PM
Ginascol John FExecutive Vice PresidentMar 02Sale77.636,606512,80566,445Mar 03 05:20 PM
Contreras JaimeSenior Vice PresidentMar 02Sale77.892,001155,85837,019Mar 03 05:19 PM
Watkin JaredSenior Vice PresidentMar 02Sale77.891,761137,16476,944Mar 03 05:19 PM
ALLEN HUBERT LExecutive Vice PresidentMar 02Sale77.891,20894,091151,896Mar 03 05:16 PM
Scoggins Christopher JSenior Vice PresidentMar 02Sale77.891,24096,58441,168Mar 03 05:15 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 02Sale77.8999977,812103,493Mar 03 05:16 PM
BRYNELSEN CHARLESSenior Vice PresidentMar 02Sale77.891,781138,72245,460Mar 03 05:13 PM
Wainer Andrea FExecutive Vice PresidentMar 02Sale77.891,429111,30549,498Mar 03 05:10 PM